Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model

Cellular Immunology

Volumn 278, Issue 1-2, 2012, Pages 55-62

  Shreewastav, Rupesh Kumar ^a   Ali, Riyasat ^a   Uppada, Jayaprakash Babu ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

FACS; Granzyme B; IFN ; LcrV; Multiple antigen peptide; Perforin; PLGA

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOLOGIC AGENT; IMMUNOLOGICAL ADJUVANT; MULTIPLE ANTIGEN PEPTIDE; MURABUTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; LAMINA PROPRIA; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH17 CELL; YERSINIA PESTIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD; DISEASE MODELS, ANIMAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; GRANZYMES; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MICE; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDES; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; TH1 CELLS; TH17 CELLS; VACCINES, SUBUNIT; YERSINIA PESTIS;

ANIMALIA; MURINAE; MUS; YERSINIA PESTIS;

EID: 84868291700     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.07.002     Document Type: Article

References (37)

1. Cornelis G.R. Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. USA 2000, 97:8778-8783.
2. Bossi P., Bricaire F. The plague possible bioterrorist act. Presse Med. 2003, 32:804-807.
3. Christopher G.W., Cieslak T.J., Pavlin J.A., Eitzen E.M. Biological warfare. A historical perspective. JAMA 1997, 278:412-417.
4. Prentice M.B., Rahalison L. Plague. Lancet 2007, 369:1196-1207.
5. Parent M.A., Berggren K.N., Kummer L.W., Wilhelm L.B., Szaba F.M., Mullarky I.K., Smiley S.T. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect. Immun. 2005, 73:7304-7310.
6. Wang S., Goguen J.D., Li F., Lu S. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge. Vaccine 2011, 39:6802-6809.
7. Matoba N., Shah N.R., Mor T.S. Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V. Vaccine 2011, 29:5584-5590.
8. Andrews G.P., Heath D.G., Anderson G.W., Welkos S.L., Friedlander A.M. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 1996, 64:2180-2187.
9. Williamson E.D., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E., Oyston P.C., Easterbrook T., Reddin K.M., Robinson A., et al. A new improved sub unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 1995, 12:223-230.
10. Goodin J.L., Powell B.S., Enama J.T., Raab R.W., Mcknown R.L., Coffman G.L., Andrews G.P. Purification and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague. Protein Expr. Purif. 2011, 76:136-144.
11. Khan A.A., Babu J.P., Gupta G., Rao D.N. Identifying B.T cell epitopes studying humoral mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Vaccine 2008, 26:316-332.
12. Gupta G., Khan A.A., Rao D.N. Cell-mediated immune response and Th1/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Scand. J. Immunol. 2010, 71:186-198.
13. Gupta G., Ali R., Khan A.A., Rao D.N. Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis. Int. Immunopharmacol. 2012, 12:64-73.
14. Uppada S.B., Bhat A.A., Sah A., Rao D.N. Enhanced humoral and mucosal immune responses after intranasalimmunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice. Vaccine 2011, 29:9352-9360.
15. Mahajan B., Berzofsky J.A., Boykins R.A., Majam V., Zheng H., Chattopadhyay R., de la vega P., Moch J.K., Haynes J.D., Belyakov I.M., Nakhasi H.L., Kumar S. Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect. Immun. 2010, 78:4613-4624.
16. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 2000, 50:147-160.
17. Reed D.S., Martinez M.J. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague. Vaccine 2006, 24:2283-2289.
18. Kowalczyk W., Monso M., de la Torre B.G., Andrew D. Synthesis of multiple antigenic peptides (MAPs)-strategies and limitations. J. peptide Sci. 2011, 17:247-251.
19. Butcher E.C., Williams M., Youngman K., Rott L., Briskin M. Lymphocyte trafficking and regional immunity. Adv. Immunol. 1999, 72:209-253.
20. Kaufmann S.H. Immunity to intracellular bacteria. Ann. Rev. Immunol. 1993, 11:129-163.
21. Kerksiek K.M., Pamer E.G. T cell responses to bacterial infection. Curr. Opin. Immunol. 1999, 11:400-405.
22. Bevan M.J. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 2004, 4:595-602.
23. Lin J.S., Park S., Adamovicz J.J., Hill J., Bliska J.B., Cote C.K., Perlin D.S., Amemiya K., Smiley S.T. TNF-α and IFN-γ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 2010, 29:357-362.
24. Szaba F.M., Kummer L.W., Wilhelm L.B., Lin J.S., Parent M.A., Montminy-Paquette S.W., Lien E., Johnson L.L., Smiley S.T. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protects against pneumonic plague. Infect. Immun. 2009, 77:4295-4304.
25. Kummer L.W., Szaba F.M., Parent M.A., Adamovicz J.J., Hill J., Johnson L.L., Smiley S.T. Antibodies and cytokines independently protect against pneumonic plague. Vaccine 2008, 26:6901-6907.
26. Lukaszewski R.A., Kenny D.J., Taylor R., Rees D.G., Hartley M.G., Oyston P.C. Pathogenesis of Yersinia pestis infection in BALB/c mice. effects on host macrophages and neutrophils. Infect. Immun. 2005, 73:7142-7150.
27. Straley S.C., Harmon P.A. Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages. Infect. Immun. 1984, 45:655-659.
28. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferongamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
29. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
30. Ma X. TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect. 2001, 3:121-129.
31. Nakajima R., Brubaker R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 1993, 61:23-31.
32. Lin J.S., Kummer L.W., Szaba F.M., Smiley S.T. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J. Immunol. 2011, 186:1675-1684.
33. Ouyang W., Kolls J.K., Zheng Y. The biological functions T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
34. O'Connor W., Zenewicz L.A., Flavell R.A. The dual nature of T(H)17 cells: shifting the focus to function. Nat. Immunol. 2010, 11:471-476.
35. S.A. Khader, G.K. Bell, J.E. Pearl, J.J. Fountain, J. Rangel-Moreno, G.E. Cilley, F. Shen, S.M. Eaton, S.L. Gaffen, S.L. Swain, R.M. Locksley, L. Haynes, T.D. Randall, A.M. Cooper, IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge, Nat. Immuolon. 8 (2007) 369-77.
36. Lin Y., Ritchea S., Logar A., Slight S., Messmer M., Rangel-Moreno J., Guglani L., Alcorn J.F., Strawbridge H., Park S.M., Onishi R., Nyugen N., Walter M.J., Pociask D., Randall T.D., Gaffen S.L., Iwakura Y., Kolls J.K., Khader S.A. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009, 31:799-810.
37. Mariathasan S., Weiss D.S., Dixit V.M., Monack D.M. Innate immunity against Francisella tularensis is dependent on the ASC/Caspase-1 axis. J. Exp. Med. 2005, 202:1043-1049.